Abstract

The efficacy of alkanoylsucroses in enhancing nasal absorption of low molecular weight heparin (LMWH) and the time span of action of these agents on the nasal membrane has been investigated. In this regard, LMWH formulated with alkanoylsucroses was administered nasally to anaesthetized male Sprague-Dawley rats and the absorption of LMWH was determined by measuring plasma anti-factor Xa activity. The duration of action of these agents at the site of administration was investigated by an in-vivo reversibility study. The potency and efficacy of dodecanoylsucrose was compared with that of sodium glycocholate. Alkanoylsucroses used in this study include dodecanoylsucrose, decanoylsucrose and octanoylsucrose. These agents enhance nasal absorption of enoxaparin in a dose-dependent and chain-length-dependent manner. Of the agents tested, dodecanoylsucrose was found to be the most potent in enhancing nasal absorption of LMWH. The bioavailability of enoxaparin formulated with alkanoylsucroses was increased by several folds compared with enoxaparin formulated in saline. The reversibility study with dodecanoylsucrose showed that the effect of alkanoylsucroses faded away with time and the duration of action of this agent at the site of administration was 120–140 min. Dodecanoylsucrose was found to be twice as potent as sodium glycocholate. Overall, the nasal absorption of LMWH was effectively enhanced by co-administration of alkanoylsucroses and the effect of alkanoylsucroses on nasal epithelium was found to be reversible. The potency of these agents depends on their hydrophobic chain lengths.

References

Ahsan
,
F.
,
Arnold
,
J. J.
,
Meezan
,
E.
,
Pillion
,
D. J.
(
2001
)
Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats
.
Pharm. Res.
 
18
:
1742
1746
.

Ahsan
,
F.
,
Arnold
,
J. J.
,
Meezan
,
E.
,
Pillion
,
D. J.
(
2003a
)
Sucrose cocoate, a component of cosmetic preparations, enhances nasal and ocular peptide absorption
.
Int. J. Pharm.
 
251
:
195
203
.

Ahsan
,
F.
,
Arnold
,
J. J.
,
Yang
,
T.
,
Meezan
,
E.
,
Schwiebert
,
E. M.
,
Pillion
,
D. J.
(
2003b
)
Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-β-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o)
.
Eur. J. Pharm. Sci.
 
20
:
27
34
.

Arnold
,
J. J.
,
Ahsan
,
F.
,
Meezan
,
E.
,
Pillion
,
D. J.
(
2002
)
Nasal administration of low molecular weight heparin
.
J. Pharm. Sci.
 
91
:
1707
1714
.

Aungst
,
B. J.
,
Rogers
,
N. J.
,
Shefter
,
E.
(
1988
)
Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter
.
J. Pharmacol. Exp. Ther.
 
244
:
23
27
.

Bagger
,
M. A.
,
Nielson
,
H. W.
,
Bechgaard
 
E.
(
2001
)
Nasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurol
.
Eur. J. Pharm. Sci.
 
14
:
69
74
.

Behl
,
C. R.
,
Pimplaskar
,
H. K.
,
Sileno
,
A. P.
,
Xia
,
W. J.
,
Gries
,
W. J.
,
DeMeireles
,
J. C.
,
Romeo
,
V. D.
(
1998
)
Optimization of systemic nasal drug delivery with pharmaceutical excipients
.
Adv. Drug Deliv. Rev.
 
29
:
117
133
.

Bianchini
,
P.
,
Bergonzini
,
G. L.
,
Parma
,
B.
,
Osima
,
B. N.
(
1995
)
Relationship between plasma anti-factor Xa activity and the antithrobotic activity of heparins of different molecular mass
.
Haemostasis
 
25
:
288
298
.

Donovan
,
M. D.
,
Huang
,
Y.
(
1998
)
Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption
.
Adv. Drug Deliv. Rev.
 
29
:
147
155
.

Hirai
,
S.
,
Yashiki
,
T.
,
Mima
,
H.
(
1981
)
Mechanisms for the enhancement of the nasal absorption of insulin by surfactants
.
Int. J. Pharm.
 
9
:
173
184
.

Ishikawa
,
F.
,
Murano
,
M.
,
Hiraishi
,
M.
,
Yamaguchi
,
T.
,
Tamai
,
I.
,
Tsuji
,
A.
(
2002
)
Insoluble powder formulation as an effective nasal drug delivery system
.
Pharm. Res.
 
19
:
1097
1104
.

Jones
,
M. N.
(
1999
)
Surfactants in membrane solubilization
.
Int. J. Pharm.
 
177
:
137
159
.

Kagatani
,
S.
,
Inaba
,
N.
,
Fukui
,
M.
,
Sonobe
,
T.
(
1998
)
Nasal absorption kinetic behavior of azetirelin and its enhancement by acylcarnitines in rats
.
Pharm. Res.
 
15
:
77
81
.

Lee
,
V. H.
,
Yamamoto
,
A.
,
Kompella
,
U. B.
(
1991
)
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption
.
Crit. Rev. Ther. Drug Carrier Syst.
 
8
:
91
192
.

Lichtenberg
,
D.
,
Robson
,
R. J.
,
Dennis
,
E. A.
(
1983
)
Solubilization of phospholipids by detergents: structural and kinetic aspects
.
Biochim. Biophys. Acta
 
737
:
285
304
.

Marttin
,
E.
,
Verhoef
,
J. C.
,
Romeijn
,
S. G.
,
Merkus
,
F. W. H. M.
(
1995
)
Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity
.
Pharm. Res.
 
12
:
1151
1157
.

Merkus
,
F. W. H. M.
,
Schipper
,
N. G. M.
,
Hermens
,
W. A. J. J.
,
Romeijn
,
S. G.
,
Verhoef
 
J. C.
(
1993
)
Absorption enhancers in nasal drug delivery: efficacy and safety
.
J. Control. Release
 
24
:
201
208
.

Merkus
,
F. W. H. M.
,
Verhoef
,
J. C.
,
Marttin
,
E.
,
Romeijn
,
S. G.
,
van der Kuy
,
P. H. M.
,
Hermens
,
W. A. J. J.
,
Schipper
,
N. G. M.
(
1999
)
Cyclodextrins in nasal drug delivery
.
Adv. Drug Deliv. Rev.
 
36
:
41
57
.

Mitragotri
,
S.
,
Kost
,
J.
(
2001
)
Transdermal delivery of heparin and low molecular weight heparin using low frequency ultrasound
.
Pharm. Res.
 
18
:
1151
1156
.

O'Hagan
,
D. T.
,
Illum
,
L.
(
1990
)
Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine
.
Crit. Rev. Ther. Drug Carrier Syst.
 
7
:
35
97
.

Pillion
,
D. J.
,
Atchison
,
J. A.
,
Gargiulo
,
C.
,
Wang
,
R. X.
,
Wang
,
P.
,
Meezan
,
E.
(
1994
)
Insulin delivery in nosedrops: new formulations containing alkylglycosides
.
Endocrinology
 
135
:
1386
1391
.

Pillion
,
D. J.
,
Hosmer
,
S.
,
Meezan
,
E.
(
1998
)
Dodecylmaltoside-mediated nasal and ocular absorption of lyspro-insulin: independence of surfactant action from multimer dissociation
.
Pharm. Res.
 
15
:
1637
1639
.

Pillion
,
D. J.
,
Ahsan
,
F.
,
Arnold
,
J. J.
,
Balusubramanian
,
B. M.
,
Piraner
,
O.
,
Meezan
,
E.
(
2002
)
Synthetic long-chain alkyl maltosides and alkyl sucrose esters as enhancers of nasal insulin absorption
.
J. Pharm. Sci.
 
91
:
1456
1462
.

Pontiroli
,
A. E.
,
Alberetto
,
M.
,
Pajetta
,
E.
,
Calderara
,
A.
,
Pozza
,
G.
(
1987
)
Human insulin plus sodium glycocholate in a nasal spray formulation: improved bioavailability and effectiveness in normal subjects
.
Diabetes Metab.
 
13
:
441
443
.

Pontiroli
,
A. E.
,
Perfetti
,
M. G.
,
Fattor
,
B.
,
Pozza
,
G.
(
1989
)
Effect of intranasal growth hormone-releasing hormone and corticotropin-releasing hormone administration on growth hormone and cortisol release: improved bioavailability by means of sodium-glycocholate
.
J. Clin. Endocrinol. Metab.
 
68
:
821
824
.

Thanou
,
M.
,
Nihot
,
M. T.
,
Jansen
,
M.
,
Verhoef
,
J. C.
,
Junginger
,
H. E.
(
2001
)
Mono-n-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo
.
J. Pharm. Sci.
 
90
:
38
45
.

Ugwoke
,
M. I.
,
Verbeke
,
N.
,
Kinget
,
R.
(
2001
)
The biopharmaceutical aspects of nasal mucoadhesive drug delivery
.
J. Pharm. Pharmacol.
 
53
:
3
22
.

Vermehren
,
C.
,
Hansen
,
H. S.
,
Thomsen
,
M. K.
(
1996
)
Time dependent effects of two absorption enhancers on the nasal absorption of growth hormone in rabbits
.
Int. J. Pharm.
 
128
:
239
250
.

Yalkowsky
,
S. H.
(
1996
)
Solubility and solubilization in aqueous media
.
Oxford University Press
,
New York
, pp
236
320
.

Footnotes

Funding: This work was supported in part by a New Investigator Award, 0265182Y, from the American Heart Association, Texas Affiliate, Austin, TX.

This content is only available as a PDF.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)